Redcliffe Labs claims to be the first in the diagnostics industry to adopt the newly launched AI-based AlinIQ Clinical Decision Support system
Redcliffe Labs has collaborated with Abbott India to introduce Clinical Decision Support (CDS) also known as AlinIQ, powered by various proprietary technologies including Big Data Engines and Artificial Intelligence (AI). This development aims to revolutionise healthcare, offering solutions to enhance patient care and convenience.
Redcliffe Labs claims to be the first in the diagnostics industry to adopt the newly launched AI-based AlinIQ Clinical Decision Support system.
The rollout took 24 months towards implementing the advanced platform. This technology aims to empower consumers, clinicians and other healthcare professionals with unparalleled insights and recommendations, revolutionising medical decisions.
In the modern healthcare landscape, the abundance of data, commonly known as ‘Big Data,’ poses challenges to clinical decision-making. Redcliffe Labs recognised the need to transform this vast data into meaningful, actionable insights. The AI-powered CDS System bridges the gap, providing healthcare professionals with user-friendly, personalised, and easy-to-interpret information.
The CDS system goes beyond traditional laboratory reporting by utilizing AI-driven algorithms to apply decision-making to individual patient cases automatically. It enables healthcare professionals to access scientific interpretations based on clinical recommendations, providing enhanced insights for better treatment decisions.
By adopting the latest AI technology, Redcliffe Labs is leading the way toward a more personalized and precise approach to healthcare, contributing to a brighter and healthier future for every Indian.
Dheeraj Jain, Founder & MD, Redcliffe Labs said, “At Redcliffe Labs, our unwavering commitment to advancing patient care through innovation and technology has led to the development of the AI based CDS system. Our state-of-the-art CDS represents a giant leap forward in the diagnostic healthcare sector, empowering our skilled clinicians with invaluable insights to provide the best possible care for our patients.”
Jamshyed Patrawala, Country Head, Abbott India emphasised that this integration marks a significant milestone in the diagnostic industry, promising to enhance the overall diagnostics landscape of the country. He believes this advancement will greatly support clinicians and provide better convenience for individuals, as they will receive comprehensive and personalised reports, unveiling their comparative health condition.